Parameters | Cirrhosis n = 355 | Non-cirrhosis n = 119 | p value |
---|---|---|---|
Age (n= 474) | |||
 Mean age ± SD | 57.21 ± 9.02 | 58.51 ± 10.43 | 0.05 |
 Median | 58.00 | 60.00 | |
Gender (n= 474) | |||
 Male | 292 (82.3%) | 104 (87.4%) | 0.19 |
 Female | 63 (17.7%) | 15 (12.6%) | |
Etiology (n= 346) | |||
 HCV | 229 (92.0%) | 90 (92.8%) | 1.00* |
 HBV | 3 (1.2%) | 1 (1.0%) | |
 Combined HCV/HBV | 2 (0.8%) | 0 (0.0%) | |
 Non-viral | 15 (6.0%) | 6 (6.2%) | |
Previous HCV treatment (n= 217) | |||
 IFN | 23 (15.4%) | 6 (8.8%) | 0.16 |
 DAAs | 86 (57.7%) | 36 (52.9%) | |
 No treatment | 40 (26.8%) | 26 (38.2%) | |
Serum AFP (n= 258) | |||
 < 200 ng/ml | 139 (74.3%) | 52 (73.2%) | 0.85 |
 ≥ 200 ng/ml | 48 (25.7%) | 19 (26.8%) | |
Tumor focality (n= 350) | |||
 Solitary | 247 (93.6%) | 73 (84.9%) | 0.01 |
 Multiple | 17 (6.4%) | 13 (15.1%) | |
Tumor size (n= 350) | |||
 Mean ± SD | 5.51 ± 3.68 | 6.59 ± 3.56 | < 0.001 |
Pathological grade (n= 443) | |||
 I | 28 (8.5%) | 5 (4.5%) | 0.15 |
 II | 253 (76.4%) | 83 (74.1%) | |
 III | 50 (15.1%) | 24 (21.4%) | |
Pathological patterns of NOS (n= 350) | |||
 Trabecular and acinar | 247 (93.6%) | 73 (84.9%) | 0.01 |
 Solid | 17 (6.4%) | 13 (15.1%) | |
Pathological stage (n= 355) | |||
 Early stage | 232 (84.4%) | 61 (76.2%) | 0.09 |
 Late stage | 43 (15.6%) | 19 (23.8%) | |
LVI (n= 358) | |||
 Negative | 157 (57.1%) | 35 (42.2%) | 0.02 |
 Positive | 118 (42.9%) | 48 (57.8%) | |
Bile duct invasion (n= 360) | |||
 Negative | 275 (100%) | 82 (96.5%) | 0.012 |
 Positive | 0 (0%) | 3 (3.5%) |